Natural Products for Bone Formation
Overview
Development of natural products from Chinese medicines for orthopedic medicines
Commercialisation opportunities
Collaborative projects on research and development
Problem addressed
Medications for osteoposisis treatment and bone healing
Innovation
- We have identified compounds from traditional Chinese medicinal plant as bone forming agents.
- These compounds are also selective and potent nuclear hormone receptor modulators that could promote bone health and ameliorate related metabolic diseases.
- First total synthesis and efficient production
Key impact
- Safe and efficacious agents for bone healing and related metabolic diseases
Application
- Treatment for bone healing and related metabolic diseases
Patent
- US patent Granted
Laboratory for Synthetic Chemistry and Chemical Biology (LSCCB) is an R&D centre funded by Health@InnoHK progamme of Innovation and Technology Commission of HKSAR. Established in 2020, LSCCB is operated with tripartite joint collaboration of The University of Hong Kong, Imperial College London and Peking University. LSCCB aims at integrating chemical and biomedical sciences to develop new molecular medicines and diagnostic tools for the treatment and analysis of human diseases, in particular, cancer. LSCCB currently assembles more than 20 principal investigators for 4 major research programmes including (a) Synthetic Chemistry; (b) Chemical Biology of Natural Products and Chinese Medicine; (c) Metal Anticancer Medicine, Diagnostics and Theranostics; and (d) Multi-Omics and Innovative Analytical Technologies for InnoHealth.
Enquiry
